Dr. Reddy's Laboratories Ltd.
Dr. Reddy's Laboratories Ltd.
🇮🇳 India, State of Telangana
1984More than 10000 peopleManufacturer/Trading Company/Service CompanyDr. Reddy's Laboratories Ltd. is a prominent Indian multinational pharmaceutical company headquartered in Hyderabad, India, with a global presence including U.S. headquarters in New Jersey. Founded in 1984, the company has grown into a major industry player employing over 24,000 people and maintaining listings on the NSE, BSE, and NYSE. As an integrated pharmaceutical firm, it operates as a manufacturer, trading company, and service provider, specializing in Active Pharmaceutical Ingredients (APIs), generic drugs, biosimilars, and proprietary formulations.
The company's extensive product portfolio encompasses over 190 medications and 60 APIs, covering critical therapeutic areas such as oncology, gastroenterology, cardiovascular health, diabetes, dermatology, and pain management. Notable products include Omeprazole, Ibuprofen, Atorvastatin, and various monoclonal antibodies. Dr. Reddy's also produces vaccines, biologics, and dietary supplements, and has recently expanded into direct-to-consumer e-commerce platforms for specialized wellness products.
With a strong commitment to quality and innovation, the company operates multiple FDA-inspected and ISO 9001/14001 certified manufacturing facilities across India and the UK. Their business model is supported by robust R&D capabilities through the Dr. Reddy's Research Foundation and international laboratories focused on novel therapeutics. The company serves a diverse global clientele, including major pharmaceutical firms like Novo Nordisk and Merck & Co., and provides contract manufacturing (OEM) and discovery services through its Aurigene Pharmaceutical Services segment.
OEM manufacturerOffers OEM services for customized brand manufacturing.
Own brandOwns and operates its own brands and manufacturing facilities.
High capacity factoryCan handle large-scale or bulk production orders.
High-tech enterpriseRecognized as a high-tech or innovative enterprise.
Contact
*****************
1
*************
1
Customers
DR REDDY S LABORATORIES
********
*********
*******
********
Unlock all 1012 customers
Certifications
FDA1
ISO 90011
ISO 140011
Ask AI about this supplier
Key export market
Shipments
Shipments count
0
Export volume
0 kg
Export countries
0
Customers
0
Insights
Top 5 customers
Reflecting the depth of cooperation between supplier and customersTop 5 customers
This insight is only available in the Pro planTop 5 export countries
Reflecting the supplier's export experience in target countriesTop 5 export countries
This insight is only available in the Pro planShipment count distribution
Reflecting the supplier's market business activityAll categories
Shipment count distribution
This insight is only available in the Pro planExport weight distribution (kg)
Reflecting the supplier's export scaleAll categories
Export weight distribution (kg)
This insight is only available in the Pro planExport weight trend (kg)
Reflecting the growth rate of the supplier's phased total supply volume and the fluctuation of supply volume, identifying supply peaks and troughsAll categories
Export weight trend (kg)
This insight is only available in the Pro planCIF trend (USD)
For identifying high-value cooperation periods and single order value changesAll categories
CIF trend (USD)
This insight is only available in the Pro planSimilar suppliers you may like
Airnov Healthcare Packaging
🇺🇸 United States
501-1000 peopleManufacturer/Trading CompanyHigh capacity factory
OEM manufacturer
Multinational enterprise
Industry association member
Shipments
227
Key customer
AIRNOV
Key market
🇮🇳 India
Description
Airnov Healthcare Packaging is a global leader in controlled atmosphere packaging solutions, specializing in the protection of pharmaceutical, nutraceutical, and diagnostic products from moisture and oxygen. With over 65 years of industry expertise, the company operates as a manufacturer and trading entity with a significant global footprint, including manufacturing facilities in the United States, France, China, and India. Headquartered in Belen, New Mexico, the company employs approximately 700 people and was recently acquired by Colorcon, Inc., a move that integrated its specialized packaging technologies into a broader portfolio of healthcare stability solutions.
The company’s extensive product range includes customizable drop-in solutions such as desiccant canisters, packets, capsules, and tablets utilizing silica gel and molecular sieves. Airnov also provides integrated desiccant systems, including desiccant stoppers, closures, and plastic tubes, alongside advanced embedded technologies like Advanced Desiccant Polymer (ADP®) and Oxy-Guard® Barrier Bottles. These products are engineered to meet the rigorous demands of highly-regulated healthcare industries, ensuring product integrity for ethical and OTC pharmaceuticals, health supplements, and medical devices.
Airnov maintains high quality standards with ISO 9001 and ISO 15378 certifications, reflecting its commitment to GMP compliance and manufacturing excellence. The company offers OEM services and leverages a robust international trade network, sourcing materials globally to ensure business continuity and supply chain optimization for its diverse client base.
EVALUATE
Zydus Lifesciences Ltd
🇮🇳 India
More than 10000 peopleManufacturerHigh capacity factory
Large enterprise group
Own brand
OEM manufacturer
Shipments
19571
Key customer
EVERSANA LIFE SCIENCE
Key market
🇺🇸 United States
Description
Zydus Lifesciences Ltd, also known as Cadila Healthcare Ltd, is a leading global pharmaceutical manufacturer headquartered in Ahmedabad, India. Ranking 4th in the Indian pharmaceutical industry, the company operates a vast network of over 30 manufacturing plants across India, the US, and Brazil. With a workforce exceeding 29,000 employees and a dedicated research team of 1,500 scientists, the company specializes in a diverse range of healthcare solutions including New Chemical Entities (NCEs), vaccines, biosimilars, and complex formulations such as transdermal patches and topical medications. Their extensive product portfolio covers critical therapeutic areas such as oncology, cardio-metabolic diseases, neurosciences, and inflammation. Notable innovations include TwinrabTM, the world's first biosimilar of Adalimumab (Exemptia), and India's first tetravalent inactivated influenza vaccine. As an OEM provider with significant manufacturing capabilities, Zydus Lifesciences serves regulated markets in the US and Europe, as well as high-growth regions in Latin America, South Africa, and over 25 emerging markets worldwide.
pharmaceutical products
TwinRab
